Order ID:89JHGSJE83839 | Style:APA/MLA/Harvard/Chicago | Pages:5-10 |
Instructions:
W3 Issue Review
Taylor Wester
Chamberlain University
PHIL 347N
July 19, 2021
W3 Issue Review
Ginn, S. L., Amaya, A. K., Alexander, I. E., Edelstein, M., & Abedi, M. R. (2018). Gene therapy clinical trials worldwide to 2017: An update. The journal of gene medicine, 20(5), e3015.Retrieved on 17th July 2021 from https://doi.org/10.1002/jgm.3015
This article discusses the concept of gene therapy and how it is being used in the modern medical environment. Ginn et al. (2018) assert that Gene therapy has in the recent years evolved with a huge success in genetic medicine, laying a key cornerstone for the development of medical technologies. Also, it outlines how over 2600 gene therapy clinical trials have proven important in disease control and treatments. They also discuss the progress gene therapy is causing and advancements in genome editing.The articles covers the first aspect of the critical reasoning paper.
Gabriel, W. (2017). The CRISPR-Cas9 mediated disruption in the ethics of gene therapy: an analysis of contemporary developments. Retrieved on 17th July 2021 from https://digitalwindow.vassar.edu/cgi/viewcontent.cgi?referer=https://scholar.google.com/&httpsredir=1&article=1727&context=senior_capstone
This article discusses the contextualization of gene therapy and how it has redefined the process of understanding the course of humanity from birth to death. The author discusses different concepts involved in the use of gene therapy and whether the new normal should be embraced. Gabriel asserts that indeed gene therapy is the new normal and the future for medical innovations. It is legal and we should embrace it.
Bilkey, G. A., Burns, B. L., Coles, E. P., Bowman, F. L., Beilby, J. P., Pachter, N. S., … & Weeramanthri, T. S. (2019). Genomic testing for human health and disease across the life cycle: applications and ethical, legal, and social challenges. Frontiers in public health, 7, 40.Retrieved on 17th July 2021 from https://doi.org/10.3389/fpubh.2019.00040
This article discusses the ethical, legal and social challenges that genome therapy and testing faces from early human life to the elderly and aged within the society. The article discusses the application of gene therapy and testing within the healthcare spectrum while identifying challenges at each stage and phase of life. Some of the challenges include the definition of terms used in genomic testing, and how data and information on gene testing are protected and shared. The article covers the third aspect of the critical reasoning paper.
References
Bilkey, G. A., Burns, B. L., Coles, E. P., Bowman, F. L., Beilby, J. P., Pachter, N. S., … & Weeramanthri, T. S. (2019). Genomic testing for human health and disease across the life cycle: applications and ethical, legal, and social challenges. Frontiers in public health, 7, 40.Retrieved on 17th July 2021 from https://doi.org/10.3389/fpubh.2019.00040
Gabriel, W. (2017). The CRISPR-Cas9 mediated disruption in the ethics of gene therapy: an analysis of contemporary developments. Retrieved on 17th July 2021 from https://digitalwindow.vassar.edu/cgi/viewcontent.cgi?referer=https://scholar.google.com/&httpsredir=1&article=1727&context=senior_capstone
Ginn, S. L., Amaya, A. K., Alexander, I. E., Edelstein, M., & Abedi, M. R. (2018). Gene therapy clinical trials worldwide to 2017: An update. The journal of gene medicine, 20(5), e3015.Retrieved on 17th July 2021 from https://doi.org/10.1002/jgm.3015
RUBRIC |
||||||
Excellent Quality 95-100%
|
Introduction
45-41 points The background and significance of the problem and a clear statement of the research purpose is provided. The search history is mentioned. |
Literature Support 91-84 points The background and significance of the problem and a clear statement of the research purpose is provided. The search history is mentioned. |
Methodology 58-53 points Content is well-organized with headings for each slide and bulleted lists to group related material as needed. Use of font, color, graphics, effects, etc. to enhance readability and presentation content is excellent. Length requirements of 10 slides/pages or less is met. |
|||
Average Score 50-85% |
40-38 points More depth/detail for the background and significance is needed, or the research detail is not clear. No search history information is provided. |
83-76 points Review of relevant theoretical literature is evident, but there is little integration of studies into concepts related to problem. Review is partially focused and organized. Supporting and opposing research are included. Summary of information presented is included. Conclusion may not contain a biblical integration. |
52-49 points Content is somewhat organized, but no structure is apparent. The use of font, color, graphics, effects, etc. is occasionally detracting to the presentation content. Length requirements may not be met. |
|||
Poor Quality 0-45% |
37-1 points The background and/or significance are missing. No search history information is provided. |
75-1 points Review of relevant theoretical literature is evident, but there is no integration of studies into concepts related to problem. Review is partially focused and organized. Supporting and opposing research are not included in the summary of information presented. Conclusion does not contain a biblical integration. |
48-1 points There is no clear or logical organizational structure. No logical sequence is apparent. The use of font, color, graphics, effects etc. is often detracting to the presentation content. Length requirements may not be met |
|||
You Can Also Place the Order at www.collegepaper.us/orders/ordernow or www.crucialessay.com/orders/ordernow |
W3 Issue Review 4 modern medical environment